The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence
F1000Research · 2023
DOI: 10.12688/f1000research.131333.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2023. Verfasst von Riham Ayoubi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H…. Hauptthemen laut MEDLINE: Membrane Proteins, Nerve Tissue Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, CIHR, Ontario Genomics.
Abstract (Originalsprache)
Transmembrane protein 106B (TMEM106B), a protein that is localized to the lysosome, is genetically linked to many neurodegenerative diseases and forms fibrils in diseased brains. The reproducibility of TMEM106B research would be enhanced if the community had access to well-characterized anti-TMEM106B antibodies. In this study, we characterized six commercially available TMEM106B antibodies for their performance in Western blot, immunoprecipitation, and immunofluorescence, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.
- Structural Genomics Consortium, University of Toronto, Toronto, Quebec, M5G 1L7, Canada.
ORCID-Profile: Kathleen Southern, Ritika Bhajiawala, Carl Laflamme
Förderung
- Motor Neurone Disease Association
- CIHR
- Ontario Genomics
- Mitacs
- ALS Association
- Genome Canada
- Canadian Institutes of Health Research Foundation
- ALS Canada
Zitieren
APA
Ayoubi, R., Fotouhi, M., Southern, K., Bhajiawala, R., Fanti, R., Prinos, P., McPherson, P. S., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF Consortium (2023). The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.131333.1
Vancouver
Ayoubi R, Fotouhi M, Southern K, Bhajiawala R, Fanti R, Prinos P, et al. The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2023. doi:10.12688/f1000research.131333.1
BibTeX
@article{Ayoubi2023,
author = {Ayoubi, Riham and Fotouhi, Maryam and Southern, Kathleen and Bhajiawala, Ritika and Fanti, Rebeka and Prinos, Panagiotis and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF Consortium, ABIF Consortium},
title = {The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence},
journal = {F1000Research},
year = {2023},
doi = {10.12688/f1000research.131333.1}
}
EUVIMED